Carol Ann Glowacki, MD, FACOG, Director of Urogynecology and Pelvic Reconstruction Surgery at Temple University Hospital, provided perspective to Flow Space on a new study that found taking vaginal estrogen for recurrent UTIs slashes odds of sepsis, hospitalization and death.